ERWINAZE Trademark

Trademark Overview

On Friday, February 18, 2011, a trademark application was filed for ERWINAZE with the United States Patent and Trademark Office. The USPTO has given the ERWINAZE trademark a serial number of 85245951. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 23, 2022. This trademark is owned by Health Protection Agency. The ERWINAZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions and preparations, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity; pharmaceutical compositions and preparations for the treatment of hematological neoplasms, namely, leukemia
erwinaze

General Information

Serial Number85245951
Word MarkERWINAZE
Filing DateFriday, February 18, 2011
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 23, 2022
Registration Number4147569
Registration DateTuesday, May 22, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements

Goods and ServicesPharmaceutical compositions and preparations, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity; pharmaceutical compositions and preparations for the treatment of hematological neoplasms, namely, leukemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2011
Primary Code005
First Use Anywhere DateMonday, October 31, 2011
First Use In Commerce DateMonday, October 31, 2011

Trademark Owner History

Party NamePORTON BIOPHARMA LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressPORTON, SALISBURY, WILTSHIRE SP4 0JG
GB
Party NameHealth Protection Agency
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWiltshire SP40JG
Party NameHealth Protection Agency
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWiltshire SP40JG
Party NameHealth Protection Agency
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWiltshire SP40JG

Trademark Events

Event DateEvent Description
Friday, September 23, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, September 23, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 23, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 29, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, May 22, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 14, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, April 14, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, April 13, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 12, 2018TEAS SECTION 8 RECEIVED
Wednesday, July 1, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 13, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 22, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 22, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Saturday, April 14, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, April 12, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 20, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 22, 2012USE AMENDMENT FILED
Tuesday, March 20, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, August 23, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2011NOTICE OF PUBLICATION
Monday, May 23, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 23, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2011ASSIGNED TO EXAMINER
Wednesday, April 27, 2011PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, April 22, 2011ASSIGNED TO LIE
Monday, April 18, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, February 23, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 22, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

erwinaze pharmaceutical compositions namely preparations hematological treatment leukemia activity neoplasms compounds